Skip to main content
Median Diagnostics Inc. logo

Median Diagnostics Inc. — Investor Relations & Filings

Ticker · 233250 ISIN · KR7233250000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2019-06-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 233250

About Median Diagnostics Inc.

https://www.mediandiagnostics.com/en

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company Median Diagnostics, detailing the date, location, and agenda items (specifically the appointment of a director). This type of document, which provides information to shareholders regarding an upcoming meeting and requests their participation/vote, is classified as a Proxy Solicitation & Information Statement.
2019-06-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Extraordinary General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share buyback, it falls under the general regulatory filing category.
2019-06-14 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a short, structured announcement reporting the results of an Investor Relations (IR) meeting held by Median Diagnostics. It provides details such as the date, location, attendees, and a summary of the topics discussed (company status, outlook, Q&A). Since it is a brief notification regarding the occurrence and outcome of an event rather than the full presentation deck itself, and it serves as a regulatory disclosure of the event, it fits the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2019-05-24 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting, and explicitly states that materials will be distributed at the event and results will be disclosed later. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it fits the criteria for a Regulatory Filing (RNS) or a general announcement.
2019-05-13 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2018, submitted to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial information, company history, business operations, and management details. This is the standard format for an annual financial filing in South Korea, which corresponds to the 10-K category in the provided schema. FY 2018
2019-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This aligns perfectly with the definition of a Declaration of Voting Results (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2019-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.